{
  "data": [
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "14 ( 24.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "7 ( 87.5)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "49 ( 38.6)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "19 ( 86.4)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "132.07 (5.6 - 204.7)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "116.43 (0.9 - 204.7)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "169.43 (0.4 - 241.9)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "127.43 (0.3 - 219.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "4 ( 6.9)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "3 ( 37.5)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "18 ( 14.2)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "10 ( 45.5)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "0.86 (0.1 - 2.4)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "0.14 (0.1 - 0.9)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.00 (0.1 - 107.6)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "0.71 (0.1 - 3.6)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "0.94 (0.4 - 1.8)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.28 (0.4 - 1.8)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.03 (0.5 - 3.8)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.04 (0.6 - 3.8)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "1 ( 1.7)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "1 ( 12.5)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "9 ( 7.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "5 ( 22.7)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "4.29 (4.3 - 4.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "0.57 (0.6 - 0.6)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "119.43 (0.9 - 215.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "119.43 (0.9 - 199.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "4 ( 10.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "3 ( 37.5)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "14 ( 23.7)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "7 ( 53.8)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "59.21 (14.1 - 196.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "29.00 (2.6 - 89.4)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "4.64 (0.4 - 142.7)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "4.43 (1.7 - 7.6)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "4 ( 10.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "3 ( 37.5)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "11 ( 18.6)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "7 ( 53.8)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "5.21 (2.6 - 6.9)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "5.57 (2.6 - 6.9)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "2.29 (0.4 - 9.6)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "2.29 (0.7 - 5.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.03 (0.5 - 1.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.04 (1.0 - 1.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.27 (0.7 - 2.4)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.27 (1.1 - 2.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "2 ( 5.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "1 ( 12.5)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "10 ( 16.9)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "5 ( 38.5)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "48.79 (9.3 - 88.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "88.29 (88.3 - 88.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "3.93 (1.3 - 142.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "2.86 (1.3 - 5.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "5 ( 71.4)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "2 (100.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "6 ( 50.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "3 (100.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "7.71 (4.7 - 38.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "19.29 (0.4 - 38.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "7.29 (2.7 - 159.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "11.43 (4.9 - 159.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "4 ( 57.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "2 (100.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "6 ( 50.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "3 (100.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "4.79 (3.0 - 38.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "19.29 (0.4 - 38.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "3.00 (0.6 - 6.7)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "3.29 (1.9 - 3.9)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.16 (0.8 - 1.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.25 (1.2 - 1.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.77 (0.5 - 14.7)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "3.61 (0.9 - 14.7)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "1 ( 14.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "5 ( 41.7)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "3 (100.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "6.57 (6.6 - 6.6)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "6.86 (4.4 - 157.9)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "11.0 (4.4 - 157.9)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "5 ( 55.6)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "2 (100.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "2.71 (1.1 - 44.4)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.29 (1.1 - 1.4)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "4 ( 44.4)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "2 (100.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.57 (1.1 - 4.7)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.29 (1.1 - 1.4)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.38 (0.5 - 1.6)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.38 (1.2 - 1.5)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "2 ( 22.2)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "1 ( 50.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "6.71 (2.3 - 11.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.00 (1.0 - 1.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "34 ( 34.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "3 (100.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "38 ( 27.9)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "6 ( 85.7)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "3 ( 13.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "1 ( 33.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "25.57 (0.1 - 238.9)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.14 (0.9 - 2.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "23.64 (0.6 - 195.6)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "3.21 (0.7 - 163.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "15.29 (4.0 - 39.7)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "39.71 (39.7 - 39.7)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "4 ( 4.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "2 ( 66.7)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "12 ( 8.8)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "4 ( 57.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "2.00 (1.3 - 6.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "0.93 (0.6 - 1.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.21 (0.6 - 14.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.07 (0.9 - 4.6)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "0.70 (0.4 - 1.4)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "0.94 (0.4 - 1.4)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.01 (0.5 - 3048.8)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "0.77 (0.5 - 1.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "3 ( 3.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "5 ( 3.7)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "3 ( 42.9)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "6.00 (0.6 - 111.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "32.00 (2.1 - 155.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "0.71 (0.7 - 147.9)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "2 ( 25.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "3 ( 18.8)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "6 ( 54.5)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED IMMUNE MODULATING MEDICATION (%)",
      "stat": "2 (100.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "0.14 (0.1 - 0.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "0.14 (0.1 - 107.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "0.14 (0.1 - 0.4)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "TOTAL DURATION OF IMMUNE MODULATING MEDICATION (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "0.29 (0.1 - 0.4)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "2 ( 12.5)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "4 ( 36.4)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO RECEIVED CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (%)",
      "stat": "2 (100.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "0.14 (0.1 - 0.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "0.14 (0.1 - 0.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "0.14 (0.1 - 0.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.14 (1.0 - 1.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.01 (0.9 - 2.7)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "INITIAL DOSE (MG/KG) OF CORTICOSTERIOD AT A DOSE >= 40 MG PREDNISONE OR EQUIVALENT\n MEDIAN ~~(MIN-MAX)",
      "stat": "1.79 (0.9 - 2.7)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 0"
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "1 ( 9.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "SUBJECTS WHO UNDERWENT CORTICOSTERIOD TAPER (%)",
      "stat": "1 ( 50.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm C: Chemo N = 115",
      "colgroup2": "colgroup2",
      "colgroup2_level": ""
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 8"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "~~~",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 127"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "0.29 (0.3 - 0.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Grade 3-5 N = 22"
    },
    {
      "variable": "DURATION OF CORTICOSTEROID TAPER (WEEKS)\n MEDIAN ~~(MIN-MAX)",
      "stat": "0.29 (0.3 - 0.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Arm B: Nivo + Ipi N = 352",
      "colgroup2": "colgroup2",
      "colgroup2_level": "Any Grade N = 0"
    }
  ],
  "metadata": {
    "source_file": "rt-im-imrslaedur.rtf",
    "parser": "RTF row-based parser with hierarchical support",
    "timestamp": "2025-07-10 12:51:30",
    "title": "Table 14.1.5.10.1\nDuration of Immune Modulating Medication for Drug-Related Select Adverse Event\nManagement Summary\nwith 30 Days Follow Up by Category\nAll Treated Subjects\nWho Experienced at Least One Drug-Related Select Adverse Event from the Category",
    "footnotes": ["Excludes data collected on or after first crossover dose date. MedDRA Version 27.0; CTC Version 5.0 Denominator is based on the number of subjects who experienced the event. Includes events reported after the first dose and within 30 days of last dose of study therapy. UMC WHODrug Global Dictionary: GLOBALB3Mar24", "Program Source: <path to program> 11JUN2025 20:25"]
  }
}
